Cancer

Results: 63571



#Item
601

NOTCH3 Protein Expression and Outcome in Small Cell Lung Cancer (SCLC) and Therapeutic Targeting with Tarextumab (Anti-Notch 2/3)

Add to Reading List

Source URL: posters.omed.s3.amazonaws.com

- Date: 2015-12-11 14:21:05
    602

    Phase 1b study of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Colin Weekes,1

    Add to Reading List

    Source URL: publications.oncomed.com

    - Date: 2016-10-09 05:13:10
      603

      Machine Learning Approaches to Breast Cancer Diagnosis and Treatment Response Prediction Katie Planey, Stanford Biomedical Informatics 1. Introduction Given the disease severity and wellpublicized philanthropic efforts c

      Add to Reading List

      Source URL: cs229.stanford.edu

      - Date: 2012-01-24 22:54:15
        604

        UNIVERSIDAD CENTRAL DEL ECUADOR DIRECCIÓN DE COMUNICACIÓN Y CULTURA BOLETÍN DE PRENSA N° 701 1 de diciembre deForo universitario discutió el cáncer en la ciudad

        Add to Reading List

        Source URL: aka-cdn.uce.edu.ec

        - Date: 2016-12-01 16:52:47
          605

          · BREAST CANCER · Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGBAlliance) Study Design and Baseline Data Ogheneruona Apoe, MD, Sin-Ho Jung, PhD, Heshan Liu, Drew K Seisler, Jayne Charla

          Add to Reading List

          Source URL: gotoper-com.s3.amazonaws.com

          - Date: 2016-09-06 09:16:10
            606

            GENE PROFILING IN BREAST CANCER Clinical Decision Making in Stage I and II Breast Cancer Patients Based on Gene Profiling Masood Pasha Syed, MD; Shalini Kolluri, MD; Janeiro Valle Goffin, MD; and Debu Tripathy, MD

            Add to Reading List

            Source URL: gotoper-com.s3.amazonaws.com

            - Date: 2016-12-05 13:14:30
              607

              Graduate Division of Biological and Biomedical Sciences Molecular and Systems Pharmacology Each year brings the development of exciting new therapeutics in the treatment of cancer, heart disease, AIDS, diabetes, psychia

              Add to Reading List

              Source URL: www.biomed.emory.edu

              - Date: 2013-09-06 21:46:38
                608

                Targeting Notch/Delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways by an anti-DLL4/Anti-VEGF bi-specific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency in

                Add to Reading List

                Source URL: posters.omed.s3.amazonaws.com

                - Date: 2015-06-12 10:36:45
                  609

                  Safety and preliminary efficacy results of a first-in-human phase I study of the novel cancer stem cell (CSC) targeting antibody brontictuzumab (OMP-52M51, anti-Notch1) administered intravenously to patients with certain

                  Add to Reading List

                  Source URL: posters.omed.s3.amazonaws.com

                  - Date: 2015-11-04 11:34:18
                    610

                    Due to the reclaimed nature of the materials used, we are providing the following warning, as required by law: WARNING: This product contains a chemical known to the State of California to cause cancer, birth defects or

                    Add to Reading List

                    Source URL: data.uncommongoods.com.edgesuite.net

                    - Date: 2015-10-26 16:30:04
                      UPDATE